Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | P. Hubel et al., Nature Immunology, 2019, 20: 493–502, https://doi.org/10.1038/s41590-019-0323-3. | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H. Brunton et al., Mol. Cell. Biol., Oct 2011; 31: 4022 - 4035 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. V. Karagounis et al., British Journal of Cancer, 2016, 115: 312-321; doi: 10.1038/bjc.2016.202 | Link | |
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. V. Rao et al., BMC Cancer, 2017, 17:68, DOI 10.1186/s12885-017-3055-5 | Link | |
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | H. Jee, Dissertation, 2013, Seoul National University | Link | |
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | H.-K. Lee, PhD Thesis, 2015, Seoul National University | Link | ||
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | H. Jee et al., BMB Reports, 2013, 46(1): 25-30, doi.org/10.5483/BMBRep.2013.46.1.078 | Link | ||
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | G. Maubach et al., EMBO reports, 2021, 22: e52878, DOI10.15252/embr.202152878 | Link | ||
AGS-Gr |
Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | S. Bhandari et al., Biochem. and Biophys. Res. Commun., 2016, 475: 119-124 | |||||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | T. S. Steigedal et al., In Vitro Cell. Dev.Biol. - Animal, 2013, 49: 162–169, DOI 10.1007/s11626-013-9588-2 | Link | ||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L.-K. M. Selvik et al., PLoS ONE, 2014, 9(11): e112485, doi:10.1371/journal.pone.0112485 | Link | ||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Bhandari et al., Biochem. and Biophys. Res. Commun., 2016, 475: 119-124 | |||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | K. Misund et al., PLoS ONE, 2013, 8(9): e76234, doi:10.1371/journal.pone.0076234 | Link | |||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L.-K. M. Selvik et al., PLoS ONE, 2014, 9(11): e112485, doi:10.1371/journal.pone.0112485 | Link | ||
ASC |
Human adipose derived stem cells | Human | other | stem cell | adherent | plasmid | Metafectene PRO | publication | J. Grillari et al., 2015, Patent US9212362B2 | Link | |||
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | ||
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | |
BE(2)M17 |
Human neuroblastoma cells | ATCC CRL-2267 | Human | brain | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
BEAS-2B |
Human bronchial epithelial cell line | ATCC CRL-9609 | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | C. Maucksch et al., Nucleic Acids Res., Oct 2008; 36: 5462 - 5471 | Link | ||
BTEC |
Human brain glioblastoma endothelial cells | Human | brain | unknown | plasmid | Metafectene PRO | publication | G. Tabatabai et al., Brain, Oct 2008; 131: 2579 - 2595 | Link | ||||
BxPC3 |
Human pancreatic adenocarcinoma cell line | ATCC CRL-1687 | Human | digestive organs | cell line | adherent | siRNA | Metafectene PRO | publication | Y. Chen et al., Mol. Cancer Res., 2017, 15 (4): 418-28, DOI: 10.1158/1541-7786.MCR-16-0366 | |||
BxPC3 |
Human pancreatic adenocarcinoma cell line | ATCC CRL-1687 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | Y. Chen et al., Mol. Cancer Res., 2017, 15 (4): 418-28, DOI: 10.1158/1541-7786.MCR-16-0366 | |||
C4-2 |
Human prostate carcinoma cell line (derivative of LNCaP) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | R.C. Peery, Dissertation,, 2020, Indiana University | Link | ||
CAFs |
Human cancer-associated fibroblasts (patient derived) | Human | unknown | primary cell | adherent | miRNA | Metafectene PRO | publication | G. T. Noh, Dissertation, 2021, The Graduate School Yonsei University | Link | |||
Caki-1 |
Human kidney clear cell carcinoma cell line | ATCC HTB-46 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | T. Liu et al., Mol. Cancer Ther., May 2009; 8: 1227 - 1238 | Link |